Collaboration between pharma and patient organisations can yield fantastic results – but conflict of interest concerns can stop such potential-filled partnerships getting off the ground.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.